Singapore markets closed

Bristol-Myers Squibb Company (BMY)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
76.71+0.01 (+0.01%)
As of 11:43AM EDT. Market open.
Full screen
Loading interactive chart…
  • Motley Fool

    Why Roche Needs to Invest in At-Home Diagnostics

    As the leader in medical diagnostics, Roche (OTC: RHHB.F) acted quickly to deliver valuable COVID-19 screening tests to the marketplace. Assisted by COVID-related sales, its diagnostics division is now delivering stronger growth than its larger pharmaceuticals division. Roche's medical diagnostics division saw strong growth throughout 2021 and into the begining of 2022.

  • Zacks

    Merck's (MRK) Keytruda Gets CHMP Nod for Expanded Melanoma Use

    Merck's (MRK) anti-PD-1 therapy Keytruda nears potential approval as an adjuvant treatment for adolescent pediatric patients with stage IIB, IIC or III melanoma following complete resection.

  • Zacks

    Mirati (MRTX) Seeks EU Nod for Adagrasib to Treat Lung Cancer

    Mirati (MRTX) seeks a nod for its lung cancer candidate adagrasib in the European Union. A regulatory filing in the United States is currently under the FDA review with decision pending this year-end.